跳至主要内容
临床试验/NCT06199752
NCT06199752已完成4 期

Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma

Theodor Bilharz Research Institute2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2021年12月12日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
90
试验地点
2
主要终点
Immunohistochemistry testing for immune cells infiltration and interferon-gamma expression

研究概览

简要总结

The goal of this interventional study was to evaluate the synergistic effect of symbiotics (a combination of probiotics and prebiotics) compared to probiotics alone in terms of their impact on anti-tumor immunomodulation in patients with pancreatic ductal adenocarcinoma (PDAC). The study also aimed to assess the effects of these interventions on postoperative complications and outcomes. In the study, a probiotic agent (Nowfoods, USA), containing ten strains of bacteria with a total dosage of 25 billion colony-forming units (CFU) was administered. This probiotic regimen involved taking two capsules once daily, starting two weeks before the surgery and continuing for one month after the surgery. For the synbiotic group, in addition to the probiotic agent, two capsules per day of inulin supplement (HERBAMAMA, USA) were also taken.

The study included three groups: the synbiotics group, the probiotics group, and the placebo group. The researchers compared the pathological status of immune cell infiltration (specifically CD8 cells) and interferon-gamma expression, as well as the levels of interleukins 10, 6, and 10 in the participants' serum. Four blood samples were collected from each participant: one taken 14 days before the surgery, one on the surgery date, one two weeks after the surgery, and one 30 days after the surgery.

The main research question addressed by the study was whether there was a significant difference in the immunomodulatory effect and postoperative complications between the synbiotics group and the probiotics group. The placebo group likely served as a control to compare the effects of the interventions against no intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with primary PDAC with complete pathological and follow-up data
  • Patients without long-distance metastasis
  • Patients without chronic diseases
  • Patients without any treatments before the surgery.

排除标准

  • Patients who suffered from other tumors or other chronic diseases or accidentally died
  • Lack of pathological and follow-up data.
  • Patients with long-distance metastasis before the surgery.

结局指标

主要结局

Immunohistochemistry testing for immune cells infiltration and interferon-gamma expression

时间窗: IHC testing for formalin fixed paraffin embedded block for all subjects 10 months from the beginning of the study, as we collected the all samples

Change in the percentage of infiltrating CD8T cells in the tumor tissue as well as the interferon-gamma in synbiotics group

Post-operative -non-infectious complications- improvement

时间窗: 1-4 weeks post operative

Testing the percentage of subjects having Anastomotic Leakage, Diarrhea, Abdominal distension

Post-operative -infectious complications improvement

时间窗: 1-4 weeks post operative

Testing the percentage of subjects having Bacteremia, Wound infection, Pneumonia, Urinary tract infection

Inflammatory cytokines level

时间窗: 10 months after collection of all blood samples from included subjects

A change in the inflammatory cytokines levels (IL 10, IL6, and IL 1 β) in synbiotics-treated group with a significant difference rather the placebo and probiotics only treated groups

Post-operative improvement days

时间窗: first day post operative till 20 days

Number of days for first stool, stay in the hospital and return to usual activity

Statistical analysis of the results

时间窗: 11 months from the beginning of the study

To assess the significance of changes in the percentage of CD8 cells in the tissue in all subjected groups as well as the expression of Interferon-gamma protein. Also, the concentration of circulating cytokines including IL B, IL6, and IL 10. Data were analyzed using statistical software package (IBM-SPSS) version 23 software. Kolmogorov-Smirnov test showed that the raw data were normally distributed. One ANOVA was applied to study the effect of treatment on the studied parameters. Two-way ANOVA was applied to study the effect of time and treatment on the studied parameters. The least significant difference (LSD) test was used to illustrate the statistical differences among the experimental groups. Duncan's test was used to illustrate the homogeneity among the different intervals. Data is displayed as mean ± standard error of the mean.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maher Sara

Dr

Theodor Bilharz Research Institute

研究点 (2)

Loading locations...

相似试验